CRISPR-Cas9: Genome Engineering and Future Vaccine Applications

Area of Science:

• Molecular Biology
• Immunology
• Biotechnology

Background:

• CRISPR-Cas9, originating from prokaryotic immunity, is a powerful genome engineering tool.
• Its application in vaccine design is rapidly evolving but underexplored.
• Derivative platforms like base editing and prime editing expand CRISPR's utility.

Purpose of the Study:

• To critically synthesize the application of CRISPR-Cas9 and its derivatives in rational vaccine design.
• To analyze the repurposing of CRISPR technology from gene editing to vaccinology.
• To outline a framework for developing precision vaccines using CRISPR.

Main Methods:

• Review of current literature on CRISPR-Cas9 applications in vaccinology.
• Analysis of CRISPR-mediated precision in engineering vaccine vectors, antigens, and immune responses.
• Evaluation of preclinical and clinical data regarding CRISPR-based vaccine strategies.

Main Results:

• CRISPR-Cas9 enables rapid engineering of novel vaccine vectors and attenuated strains.
• Precise optimization of antigen sequences for enhanced vaccine breadth and potency is achievable.
• Direct modulation of host immune responses via CRISPR is a promising avenue.

Conclusions:

• CRISPR technology offers a paradigm shift towards rational, programmable vaccine development.
• Significant hurdles in safety, delivery, and regulation must be overcome for widespread adoption.
• Leveraging CRISPR can accelerate the creation of next-generation vaccines against diverse pathogens.